This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Complement component C7P10643Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system.
Cell Host Microbe. 2013 May 15;13(5):521-34. doi: 10.1016/j.chom.2013.04.009.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes.
Sci Rep. 2014 Aug 29;4:6232. doi: 10.1038/srep06232.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Perturbations in the urinary exosome in transplant rejection.
Front Med (Lausanne). 2015 Jan 5;1:57. doi: 10.3389/fmed.2014.00057. eCollection 2014.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomes released from breast cancer carcinomas stimulate cell movement.
PLoS One. 2015 Mar 23;10(3):e0117495. doi: 10.1371/journal.pone.0117495. eCollection 2015.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Identification of distinct circulating exosomes in Parkinson's disease.
Ann Clin Transl Neurol. 2015 Apr;2(4):353-61. doi: 10.1002/acn3.175. Epub 2015 Feb 6.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.
Sci Rep. 2017 Feb 20;7:42741. doi: 10.1038/srep42741.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.
Sci Rep. 2017 Feb 20;7:42741. doi: 10.1038/srep42741.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation.
Int J Radiat Biol. 2017 Mar 7:1-12. doi: 10.1080/09553002.2017.1294772.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation.
Int J Radiat Biol. 2017 Mar 7:1-12. doi: 10.1080/09553002.2017.1294772.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.
Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.
Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Differential protein expression in exosomal samples taken from trauma patients.
Proteomics Clin Appl. 2017 May 25. doi: 10.1002/prca.201700061.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.
Nat Commun. 2017 Jun 6;8:15729. doi: 10.1038/ncomms15728.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity.
Sci Rep. 2017 Jul 5;7(1):4711. doi: 10.1038/s41598-017-05002-y.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity.
Sci Rep. 2017 Jul 5;7(1):4711. doi: 10.1038/s41598-017-05002-y.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
Sci Rep. 2017 Oct 6;7(1):12782. doi: 10.1038/s41598-017-13092-x.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Amniotic fluid stem cell exosomes: Therapeutic perspective.
Biofactors. 2018 Jan 16. doi: 10.1002/biof.1407.
ENOG410YJ70120 / 0 / 120
Complement component C7P10643Biologically active constituents of the secretome of human W8B2(+) cardiac stem cells.
Sci Rep. 2018 Jan 25;8(1):1579. doi: 10.1038/s41598-018-19855-4.
ENOG410YJ70120 / 0 / 120
[1]